Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Breast Cancer 2024

Is low dose endocrine therapy the new standard for breast cancer chemo prevention?

Second vote and conclusions/discussion

Date

16 May 2024

Session

Is low dose endocrine therapy the new standard for breast cancer chemo prevention?

Presenters

Javier Cortes

Authors

J. Cortes

Author affiliations

  • International Breast Cancer Center, Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction and first vote

Presenter: Javier Cortes

Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?

Resources:

Slides

Webcast

Yes

Presenter: Andrea De Censi

Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?

Resources:

Slides

Webcast

No

Presenter: Gareth Evans

Session: Is low dose endocrine therapy the new standard for breast cancer chemo prevention?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.